Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.19)
# 3,767
Out of 5,118 analysts
70
Total ratings
36.59%
Success rate
-10.09%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $341 → $333 | $225.02 | +47.99% | 9 | Nov 25, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.52 | +98.41% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.58 | +96.51% | 5 | Nov 5, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $44.23 | +46.96% | 12 | Aug 8, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $46.15 | -13.33% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $6.93 | +15.44% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $2.69 | +160.22% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $92.78 | +34.73% | 9 | Feb 26, 2025 |
Veeva Systems
Nov 25, 2025
Maintains: Overweight
Price Target: $341 → $333
Current: $225.02
Upside: +47.99%
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.52
Upside: +98.41%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.58
Upside: +96.51%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $44.23
Upside: +46.96%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $46.15
Upside: -13.33%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $6.93
Upside: +15.44%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.69
Upside: +160.22%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $92.78
Upside: +34.73%